Literature DB >> 33479241

The impact of COVID-19 and social distancing on people with Parkinson's disease: a survey study.

Megan P Feeney1, Yaqian Xu2, Matthew Surface3, Hiral Shah3, Nora Vanegas-Arroyave4, Amanda K Chan3, Elizabeth Delaney3, Serge Przedborski5, James C Beck1,6, Roy N Alcalay7.   

Abstract

As the COVID-19 pandemic continues to affect the international community, very little is known about its impact on the health and day-to-day activities of people with Parkinson's disease (PwPD). To better understand the emotional and behavioral consequences of the public health policies implemented to mitigate the spread of SARS-CoV-2 in PwPD, and to explore the factors contributing to accessing alternative health care mechanisms, such as telehealth, we administered an anonymous knowledge, attitude, and practice survey to PwPD and care partners, via the mailing lists of the Parkinson's Foundation and Columbia University Parkinson's Disease Center of Excellence with an average response rate of 19.3%. Sufficient information was provided by 1,342 PwPD to be included in the final analysis. Approximately half of respondents reported a negative change in PD symptoms, with 45-66% reporting mood disturbances. Telehealth use increased from 9.7% prior to the pandemic to 63.5% during the pandemic. Higher income and higher education were associated with telehealth use. Services were more often used for doctor's appointment than physical, occupational, speech, or mental health therapies. Almost half (46%) of PwPD preferred to continue using telehealth always or sometimes after the coronavirus outbreak had ended. Having received support/instruction for telehealth and having a care partner, friend, or family member to help them with the telehealth visit increased the likelihood of continuous use of telehealth after the pandemic ended. Taken together, PD symptoms and management practices were markedly affected by COVID-19. Given the observed demographic limitations of telehealth, expanding its implementation to include additional physical, occupational, psychological, and speech therapies, increasing support for telehealth, as well as reaching underserved (low income) populations is urgently required.

Entities:  

Year:  2021        PMID: 33479241      PMCID: PMC7820020          DOI: 10.1038/s41531-020-00153-8

Source DB:  PubMed          Journal:  NPJ Parkinsons Dis        ISSN: 2373-8057


  31 in total

1.  Racial differences in health and health care service utilization in later life: the effect of socioeconomic status.

Authors:  J E Mutchler; J A Burr
Journal:  J Health Soc Behav       Date:  1991-12

2.  Assessing advantages and barriers to telemedicine adoption in the practice setting: A MyCareTeam(TM) exemplar.

Authors:  Shaun T L'Esperance; Donna J Perry
Journal:  J Am Assoc Nurse Pract       Date:  2015-07-14       Impact factor: 1.165

3.  Variation in COVID-19 Hospitalizations and Deaths Across New York City Boroughs.

Authors:  Rishi K Wadhera; Priya Wadhera; Prakriti Gaba; Jose F Figueroa; Karen E Joynt Maddox; Robert W Yeh; Changyu Shen
Journal:  JAMA       Date:  2020-06-02       Impact factor: 56.272

Review 4.  Evaluating barriers to adopting telemedicine worldwide: A systematic review.

Authors:  Clemens Scott Kruse; Priyanka Karem; Kelli Shifflett; Lokesh Vegi; Karuna Ravi; Matthew Brooks
Journal:  J Telemed Telecare       Date:  2016-10-16       Impact factor: 6.184

Review 5.  Role of Physical Activity in Parkinson's Disease.

Authors:  Ketaki S Bhalsing; Masoom M Abbas; Louis C S Tan
Journal:  Ann Indian Acad Neurol       Date:  2018 Oct-Dec       Impact factor: 1.383

6.  COVID-19 pandemic: perspectives on an unfolding crisis.

Authors:  A Spinelli; G Pellino
Journal:  Br J Surg       Date:  2020-03-23       Impact factor: 6.939

7.  Knowledge, Attitudes, Practices, and Burden During the COVID-19 Pandemic in People with Parkinson's Disease in Germany.

Authors:  Hannah M Zipprich; Ulrike Teschner; Otto W Witte; Aline Schönenberg; Tino Prell
Journal:  J Clin Med       Date:  2020-05-29       Impact factor: 4.241

8.  Outcome of Parkinson's Disease Patients Affected by COVID-19.

Authors:  Angelo Antonini; Valentina Leta; James Teo; K Ray Chaudhuri
Journal:  Mov Disord       Date:  2020-05-28       Impact factor: 9.698

9.  Prevalence of Depression Symptoms in US Adults Before and During the COVID-19 Pandemic.

Authors:  Catherine K Ettman; Salma M Abdalla; Gregory H Cohen; Laura Sampson; Patrick M Vivier; Sandro Galea
Journal:  JAMA Netw Open       Date:  2020-09-01

10.  An interactive web-based dashboard to track COVID-19 in real time.

Authors:  Ensheng Dong; Hongru Du; Lauren Gardner
Journal:  Lancet Infect Dis       Date:  2020-02-19       Impact factor: 25.071

View more
  22 in total

1.  Parkinson's disease and Covid-19: The effect and use of telemedicine.

Authors:  Aleksandra M Podlewska; Daniel J van Wamelen
Journal:  Int Rev Neurobiol       Date:  2022-07-14       Impact factor: 4.280

Review 2.  Psychological outcomes of the COVID-19 pandemic in patients with Parkinson's disease: A systematic review.

Authors:  Fardin Nabizadeh; Zahrasadat Seyedalhosseini; Mohammad Balabandian; Mohammad Reza Rostami
Journal:  J Clin Neurosci       Date:  2022-06-28       Impact factor: 2.116

3.  COVID-19 manifestations in people with Parkinson's disease: a USA cohort.

Authors:  Yaqian Xu; Matthew Surface; Amanda K Chan; Joshua Halpern; Nora Vanegas-Arroyave; Blair Ford; Megan P Feeney; Kimberly T Kwei; Linn E Katus; Sheng-Han Kuo; Hiral Shah; Cheryl Waters; Linda M Winfield; James C Beck; Serge Przedborski; Stanley Fahn; Roy N Alcalay
Journal:  J Neurol       Date:  2021-09-04       Impact factor: 6.682

Review 4.  Immunological Interfaces: The COVID-19 Pandemic and Depression.

Authors:  Austin Perlmutter
Journal:  Front Neurol       Date:  2021-04-23       Impact factor: 4.003

5.  The Views and Needs of People With Parkinson Disease Regarding Wearable Devices for Disease Monitoring: Mixed Methods Exploration.

Authors:  Lorna Kenny; Kevin Moore; Clíona O' Riordan; Siobhan Fox; John Barton; Salvatore Tedesco; Marco Sica; Colum Crowe; Antti Alamäki; Joan Condell; Anna Nordström; Suzanne Timmons
Journal:  JMIR Form Res       Date:  2022-01-06

Review 6.  Social and psychological impact of the COVID-19 pandemic on people with Parkinson's disease: a scoping review.

Authors:  S K Brooks; D Weston; N Greenberg
Journal:  Public Health       Date:  2021-09-01       Impact factor: 4.984

Review 7.  The overall impact of COVID-19 on healthcare during the pandemic: A multidisciplinary point of view.

Authors:  Nastaran Sabetkish; Alireza Rahmani
Journal:  Health Sci Rep       Date:  2021-10-01

8.  Secondary Impact of COVID-19 Pandemic on People with Parkinson's Disease-Results of a Polish Online Survey.

Authors:  Karolina Krzysztoń; Beata Mielańczuk-Lubecka; Jakub Stolarski; Anna Poznańska; Katarzyna Kępczyńska; Agata Zdrowowicz; Izabela Domitrz; Jan Kochanowski
Journal:  Brain Sci       Date:  2021-12-26

Review 9.  Can SARS-CoV-2 Infection Lead to Neurodegeneration and Parkinson's Disease?

Authors:  Lea Krey; Meret Koroni Huber; Günter U Höglinger; Florian Wegner
Journal:  Brain Sci       Date:  2021-12-18

Review 10.  Moving Forward from the COVID-19 Pandemic: Needed Changes in Movement Disorders Care and Research.

Authors:  B Y Valdovinos; J S Modica; R B Schneider
Journal:  Curr Neurol Neurosci Rep       Date:  2022-02-02       Impact factor: 6.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.